Shares of Glenmark Pharma surged over 4 percent in early trade on December 10 after the company stated that the first clinical data of its blood cancer drug showed a positive response rate of 83 percent.  The positive development, essential for the successful clinical trial of Glenmark's blood cancer drug, bolstered sentiment for the stock.In an exchange filing, Glenmark Pharmaceuticals announced...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Glenmark Pharma, financial stocks, and more.Glenmark PharmaHSBC On Glenmark PharmaHold Call, Target Cut To `1,600/Sh From `1,660/ShQ2 Below Estimates, Mainly On Higher Overheads; Strong India Sales In Otherwise Lacklustre QuarterNew Launches And Supplies From Monroe Plant Key For Pick-Up ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and fund-raising, here’s a quick look at which stocks will be in focus in today's trade:Results TodayGodavari Biorefineries, Waaree Energies, Valecha Engineering, and Samyak International will release quarterly earnings on November 18.Quarterly EarningsHero MotoCorp Q2 (Stand...

Glenmark Pharmaceuticals share price touched a 52-week high of Rs 1,429.95 in the early trade on July 18 after the company received final approval by the United States Food & Drug Administration (USFDA) for Topiramate Capsules USP, 15 mg and 25 mg.At 09:28 am, Glenmark Pharma was quoting at Rs 1,419.90, up Rs 9.40, or 0.67 percent, on the BSE.The Topiramate capsules have been determined by the FDA...

Shares of Glenmark Life Sciences slumped as much as nearly 4 percent on July 11, a day after Glenmark Pharma's board greenlit the company's plans to offload a 7.84 percent stake in the former through an offer for sale.With this OFS, Glenmark Pharma will completely exit Glenmark Life Sciences. The floor price for the OFS is fixed at Rs 810 per share, representing a 7.5 percent discount to the previ...